Clinical Trial Update: Doxorubicin HCI Liposome Injection Versus Weekly Docetaxel in Patients First Relapse Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing Doxorubicin HCl Liposome Injection with weekly Docetaxel in patients with first-relapse metastatic breast cancer, with results posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Doxorubicin HCl Liposome Injection (liposomal doxorubicin)

Snippet

Sponsor: SCRI Development Innovations, LLC | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2013-07-19